Somagenetix
Somagenetix is a gene therapy developer for phagocyte disorders founded in 2019 by Ulrich Siler .
Email Address
info@somagenetix.com
Founded Date
2019
Founder
Latest Funding Round Date
October 10, 2024
Latest Funding Round Amount (USD)
11,661,000
Latest Funding Type
LinkedIn URL
Location
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
11,661,000
Official Website
Find more companies like Somagenetix
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.